Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

N Engl J Med. 2001 Jul 19;345(3):211-5. doi: 10.1056/NEJM200107193450311.

Authors

B R Edlin¹, K H Seal, J Lorvick, A H Kral, D H Ciccarone, L D Moore, B Lo

Affiliation

¹ Urban Health Study, Institute for Health Policy Studies, University of California, San Francisco 94110, USA. bredlin@itsa.ucsf.edu

No abstract available

MeSH terms

Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use*
Ethics, Medical*
Health Policy*
Hepatitis C / complications*
Hepatitis C / drug therapy*
Hepatitis C / epidemiology
Humans
Interferons / adverse effects
Interferons / therapeutic use*
Medical Futility
Patient Compliance
Patient Selection
Practice Guidelines as Topic
Prejudice
Recurrence
Risk
Substance Abuse, Intravenous / complications*
Substance Abuse, Intravenous / therapy
Substance-Related Disorders / complications
Substance-Related Disorders / therapy
United States / epidemiology
Withholding Treatment*

Substances

Antiviral Agents
Interferons